Biology of TGF-beta in knockout and transgenic mouse models (Q41469668)

1 October 2017

1 reference

title

Biology of TGF-beta in knockout and transgenic mouse models (English)

1 reference

1 October 2017

Böttinger EP

1

1 reference

1 October 2017

Letterio JJ

series ordinal

2

1 reference

1 October 2017

Roberts AB

series ordinal

3

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

1 October 2017

1 reference

1 October 2017

51

1 reference

1 October 2017

5

1 reference

1 October 2017

1355-1360

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1997.185

1 October 2017

0 references

cites work

The transforming growth factor-beta family

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Serine/threonine kinase receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

TGF-beta-receptor-mediated signaling

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

TGF-beta receptors and actions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Transforming growth factor-beta: activity and efficacy in animal models of wound healing

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Transforming growth factor beta: a matter of life and death

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Tumor suppressor activity of the TGF-beta pathway in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Transforming Growth Factor-beta Receptors: Role in Physiology and Disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Mechanism of activation of the TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

TGFbeta signaling: receptors, transducers, and Mad proteins.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

A human Mad protein acting as a BMP-regulated transcriptional activator

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Serine phosphorylation, chromosomal localization, and transforming growth factor-beta signal transduction by human bsp-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Mad-related genes in the human

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Receptor-associated Mad homologues synergize as effectors of the TGF-beta response

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Transforming growth factor-beta 3 is required for secondary palate fusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Escape from "horror autotoxicus": pathogenesis and treatment of autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Maternal rescue of transforming growth factor-beta 1 null mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Endoglin modulates cellular responses to TGF-beta 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Control of transforming growth factor-beta activity: latency vs. activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.185

7 January 2021

Identifiers

DOI

10.1038/KI.1997.185

1 reference

Dimensions Publication ID

1 October 2017

0 references

1 reference